IL-6 therapy does not improve glucose metabolism in diabetes

10/26/2012 | PhysiciansBriefing.com

Interleukin-6 treatment did not improve glucose metabolism in the skeletal muscle cells of type 2 diabetes patients compared with those who had normal glucose tolerance, a study indicated. However, IL-6 therapy was associated with increased fatty acid oxidation in both groups, researchers reported in Diabetes.

View Full Article in:

PhysiciansBriefing.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Counsel, Regulatory (FDA)
CareFusion
San Diego , CA
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations